Version 2.77

Description

Zomepirac is an orally effective NSAID that has antipyretic actions. It was developed by McNeil Pharmaceutical and approved by the FDA in 1980 and sold as the sodium salt, zomepirac sodium, under the brand name Zomax. Due to its clinical effectiveness, it was preferred by doctors in many situations and obtained a large share of the analgesics market; however, it was subsequently withdrawn in March 1983 due to its tendency to cause serious anaphylaxis in an unpredictable subset of the patient population. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Zomepirac

Basic Part Properties

Part Display Name
Zomepirac
Part Type
Component (Describes the core component or analyte measured)
Created On
2000-05-04
Construct for LOINC Short Name
Zomepirac

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP18141-9
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP18141-9

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 氯苯酰二甲基吡咯乙酸
Synonyms: 佐美酸;毒素
fr-CA French (Canada) Zomepirac
es-ES Spanish (Spain) Zomepirac
it-IT Italian (Italy) Zomepirac
tr-TR Turkish (Turkey) Zomepirak
ru-RU Russian (Russian Federation) Зомепирак
nl-NL Dutch (Netherlands) zomepirac
fr-BE French (Belgium) Zomepirac